Navigation Links
Olive Fertility Centre Physician Recognized for Excellence
Date:4/3/2013

Vancouver, Canada (PRWEB) April 03, 2013

Olive Fertility Centre is proud to announce that co-founder and co-director Dr. Jason Hitkari has been awarded the Outstanding Educator Award on behalf of the UBC medical class of 2014 for his contribution as Reproduction Week chair and lecturer. This is the second time Dr. Hitkari has received this award acknowledging the recipient for “extraordinary commitment to teaching and making a significant contribution to learning.”

“This award is a tremendous honour,” says Dr. Hitkari. “Reproductive Endocrinology is an exciting and rapidly changing field. And just as our technology is advancing, so is our model of patient care. As a practicing fertility doctor and educator, I am delighted to have the opportunity to share my experience and insight into fertility treatment with this talented group of future physicians.”

Dr. Hitkari is currently extremely involved in medical student education in reproduction and infertility at UBC. He also coordinates the Reproduction Seminars for the Obstetrics and Gynecology resident physicians and lectures extensively throughout BC to family practitioners, family practice residents, allied health professionals, and gynecologists.

After completing his training in Obstetrics and Gynecology at the University of British Columbia, Dr. Hitkari went on to do a formal fellowship in Reproductive Endocrinology and Infertility at Mt. Sinai Hospital in Toronto. He then returned to Vancouver, where he joined Genesis Fertility Centre as a co-director. In 2013, Dr. Hitkari left Genesis to open a new clinic, Olive Fertility Centre, with Drs. Taylor, Yuzpe, and Fluker.

“Olive Fertility Centre has been up and running since January 2013, but we are looking forward to moving into our brand new clinic at City Square in Vancouver in June 2013. We have some of the most experienced fertility specialists in Canada as part of our physician team, and we are using this experience to build our dream clinic. It will have the most up-do-date lab, exciting new technologies, and a unique model of patient-centred care where we can offer patients a highly personalized experience throughout their entire fertility treatment at Olive.”

Dr. Albert Yuzpe, who has founded two previous fertility clinics, is delighted at the opportunity the new clinic affords.

“I am more excited now, with the founding of the Olive Fertility Centre, than I have ever been in the past because we have so much more to offer our patients. It has become so obvious to us that our patients need to have a known and identified team that knows them well and to whom they can turn to with questions and concerns. Many of our former staff (who we have worked with for over a decade) are joining us at Olive. They are looking forward to moving toward our ultimate goal of “Patient-Centred Care.”

Read the full story at http://www.prweb.com/releases/2013/4/prweb10595788.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Olive Dental Group Announces a New Treatment for Sleep Apnea
2. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
3. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
4. d’Oliveira & Associates Seeks Clients That Have Been Affected by the Prescription Drug Topamax
5. d'Oliveira & Associates Offers “No Win - No Fee Promise” on Topamax Cases
6. Explaining how extra virgin olive oil protects against Alzheimers disease
7. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
8. d'Oliveira & Associates Helps Massachusetts Man Receive $100,000 in Auto Accident Settlement
9. D’Oliveira & Associates Helps Woonsocket, RI Man Receive Over $38,000 in Back Due Benefits
10. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
11. d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: